Atopic Dermatitis Treatment Market size was USD 16.12 Billion in 2022!

Global Atopic Dermatitis Treatment Market size was USD 16.12 Billion in 2022. Atopic Dermatitis Treatment Industry's Compound Annual Growth Rate will be 15.60% from 2023 to 2030. What are the key driving factors of Atopic Dermatitis Treatment Market?Increasing Awareness of Atopic Dermatitis to Provide Viable Market OutputThe market for AD people using herbal medicine, natural ointment, and ultraviolet therapy is boosted by increased awareness. Also, medical institutions provide education on AD and its primary home treatment. Furthermore, extensive research is being conducted to find fast relief for the disease. All of these factors are driving the market forward. For example, World Atopic Eczema Day was established in to raise awareness of AD internationally among Europeans. The initiative was created by the European Federation of Allergy and Airway Patients' Associations (EFA) and the International Federation of Dermatology Patients' Associations (Skin International).The FDA has approved Dupixent (dupilumab) for children between 6 months and 5 years who have moderate-to-severe atopic dermatitis that is not effectively managed with prescribed topical treatments or when those treatments are not recommended.The growth of the global atopic dermatitis market is propelled by the introduction of biologics & small molecules, premium-priced drugs that are replacing generic first-line and second-line therapeutics, and improved diagnostics. The market's growth rate is expected to be accelerated by the increasing prevalence of skin allergies and chronic disorders. The severity of atopic dermatitis varies from patient to patient, and the treatment procedures are tailored to the severity level. The rising healthcare expenditure and the growing popularity of these treatment procedures through digital advertisements are accelerating the global atopic dermatitis market growth.(Source:www.sanofi.com/en/media-room/press-releases/2022/2022-06-07-20-45-00-2458243)Factors Impacting on Atopic Dermatitis MarketLack of Skilled Healthcare Professionals to Hinder Market GrowthIn underdeveloped regions, there is a shortage of qualified healthcare professionals. This scarcity is mainly due to a lack of adequate training programs. As a result, healthcare facilities frequently require additional skilled doctors to meet the required level of care. One potential solution is for the government to offer various incentives to healthcare workers in public-sector hospitals and health centers. Some developed countries have tackled a similar problem by implementing reimbursement systems based on capitation and a pay-for-performance model. These approaches help balance the need to expand services and budget constraints.Impact of COVID-19 on Atopic Dermatitis TreatmentThe COVID-19 outbreak has caused more people to wash their hands frequently, resulting in dry and cracked skin that is more prone to infections in individuals with atopic dermatitis. Hand eczema has also increased due to repeated exposure to harsh soaps and hand sanitizers that strip the skin of natural oils. The pandemic has significantly impacted market growth during the peak stages of the COVID-19 crisis. However, with the easing of strict regulations on patient consultations at healthcare centers, the market is expected to experience growth in the forecast period. Introduction of Atopic Dermatitis TreatmentHaving a chronic condition called atopic dermatitis causes by red, itchy, swollen, and cracked skin. Treatment is necessary due to the possibility of white fluid leaking from the affected area. Typically starting in childhood, atopic dermatitis can worsen as one grows older. Several factors can cause atopic dermatitis, such as genetic abnormalities, environmental exposure, immune system dysfunction, and issues with skin permeability. Atopic dermatitis is more common overall, and as a result, the market for this condition is projected to experience significant growth thanks to ongoing advancements in drug development. The market is expected to expand due to the increasing demand for new biological and approved products, further driving the growth of the atopic dermatitis market. These developments empower businesses to offer better-tailored solutions and services, which, in turn, contribute to the growth of the atopic dermatitis industry. LEO Pharma A/S, a leading company in the fi...

全球特应性皮炎治疗市场规模于2022年达到161.2亿美元。从2023年至2030年，特应性皮炎治疗行业的复合年增长率预计为15.60%。特应性皮炎治疗市场的关键驱动力是什么？对特应性皮炎的认识不断加深，为市场提供切实可行的产出。使用草药、天然膏剂和紫外线疗法的人群市场因认识提高而得到推动。此外，医疗机构提供关于特应性皮炎及其主要家庭治疗的教育。进一步地，正在开展广泛的研究以寻求疾病的快速缓解。所有这些因素都在推动市场前进。例如，世界特应性湿疹日被设立，旨在提高欧洲人对特应性皮炎的国际认识。该倡议由欧洲过敏和呼吸道患者协会（EFA）以及国际皮肤病学患者协会（Skin International）发起。美国食品药品监督管理局（FDA）已批准Dupixent（dupilumab）用于6个月至5岁的儿童，这些儿童患有中度至重度特应性皮炎，且无法通过处方外用药有效管理或当这些治疗方法不推荐时。全球特应性皮炎市场的增长由生物制剂和Small Molecules的引入、高价药物替代首线和二线通用疗法，以及诊断技术的改进所推动。市场增长率的提升预期将得益于皮肤过敏和慢性疾病的日益普遍。特应性皮炎的严重程度因人而异，治疗方案根据严重程度进行定制。医疗保健支出的增加以及这些治疗程序通过数字广告的日益普及正在加速全球特应性皮炎市场的增长。（来源：www.sanofi.com/en/media-room/press-releases/2022/2022-06-07-20-45-00-2458243）影响特应性皮炎市场的因素缺乏熟练的医疗保健专业人员将阻碍市场增长。在欠发达地区，合格医疗保健专业人员短缺，这主要是由于缺乏足够的培训项目。因此，医疗设施经常需要额外熟练的医生以满足所需的护理水平。一个潜在的解决方案是政府为公立医院和卫生中心的医疗保健工作者提供各种激励措施。一些发达国家通过实施基于人头费和绩效付费模式的补偿制度来解决类似问题。这些方法有助于平衡扩大服务与预算限制的需求。COVID-19对特应性皮炎治疗的影响COVID-19疫情的爆发导致更多人频繁洗手，这增加了特应性皮炎患者干裂皮肤的感染风险。由于反复接触会剥夺皮肤自然油脂的强力肥皂和洗手液，手部湿疹也有所增加。在COVID-19危机的高峰阶段，疫情对市场增长产生了重大影响。然而，随着对医疗中心患者咨询的严格规定的放宽，预计市场将在预测期内实现增长。特应性皮炎治疗的新引入患有慢性疾病特应性皮炎会导致皮肤发红、瘙痒、肿胀和开裂。由于受影响区域可能渗出白色液体，治疗是必要的。通常在儿童时期开始，特应性皮炎会随着年龄的增长而恶化。多种因素可导致特应性皮炎，例如遗传异常、环境暴露、免疫系统功能障碍和皮肤渗透性问题。特应性皮炎总体上更为常见，因此，由于药物开发的持续进步，预计该疾病的市场将经历显著增长。市场预计将因对新型生物制剂和已批准产品的需求增加而扩大，进一步推动特应性皮炎市场的增长。这些发展使企业能够提供更定制化的解决方案和服务，从而反过来促进特应性皮炎行业的发展。LEO Pharma A/S，一家在特应性皮炎行业领先的制药公司……